helium
ga
discov
french
astronom
isol
earth
molecular
weight
determin
physic
chemic
characterist
consist
low
molecular
weight
low
densiti
one
third
densiti
oxygen
high
viscos
high
diffus
coeffici
greater
carbon
monoxid
biolog
inert
ga
use
clinic
practic
base
characterist
commerci
find
mixtur
concentr
helium
oxygen
respect
helium
oxygen
concentr
clinic
applic
describ
primarili
obstruct
diseas
asthma
bronchiol
laryng
due
physicalchem
properti
mixtur
especi
low
densiti
high
viscos
direct
influenc
flow
resist
respiratori
system
barach
et
al
confirm
use
heliumoxygen
mixtur
heliox
decreas
transpulmonari
pressur
improv
tidal
volum
experiment
studi
tracheostom
dog
physiolog
proxim
airway
turbul
flow
pattern
becom
laminar
termin
airway
patient
obstruct
diseas
turbul
flow
proxim
airway
worsen
respiratori
distress
decreas
lung
ventil
use
heliox
chang
flow
pattern
proxim
airway
turbul
laminar
thu
decreas
respiratori
work
report
use
children
asthma
shown
conflict
result
convent
treatment
suffici
case
diseas
exacerb
sinc
expens
ga
oxygen
use
first
choic
wherea
sever
case
seem
benefici
earli
use
decreas
respiratori
work
dyspnea
great
differ
establish
consensu
use
children
due
differ
criteria
relat
inclus
time
intervent
treatment
given
sever
diseas
known
studi
role
exacerb
asthma
yet
determin
hand
studi
identifi
effect
product
particl
jet
nebul
deliveri
efficaci
aerosol
relat
low
densiti
becom
laminar
turbul
flow
improv
ventil
high
resist
area
afford
optim
aerosol
deposit
lower
airway
use
heliumoxygen
mixtur
restrict
patient
spontan
breath
benefit
may
associ
use
noninvas
even
invas
ventil
long
synergist
treatment
taken
consider
effect
decreas
inflammatori
process
respiratori
distress
syndrom
patient
despit
confirm
yet
understood
even
clinic
applic
heliumoxygen
mixtur
gain
promin
intens
therapi
environ
even
though
still
consensu
use
evalu
efficaci
clinic
respons
use
heliumoxygen
mixtur
patient
sever
obstruct
condit
organ
protocol
use
heliumoxygen
mixtur
includ
patient
diagnos
bronchospasm
andor
wheez
maintain
wood
score
tabl
one
hour
convent
treatment
regardless
fraction
oxygen
previous
use
use
salbutamol
predinisolon
methylpredinisolon
inhal
hyperton
solut
antibiot
respiratori
physic
therapi
oxygen
therapi
consid
convent
treatment
maintain
even
initi
heliumoxygen
mixtur
instal
heliumoxygen
mixtur
torpedo
use
concentr
helium
oxygen
specif
nonrebreath
mask
figur
flow
patient
maintain
mixtur
enrich
total
de
oxygen
patient
maintain
oxygen
andor
present
improv
sever
score
one
hour
use
discontinu
sampl
calcul
base
studi
camboni
et
al
assum
mean
respiratori
distress
score
standard
deviat
thu
estim
sampl
ten
individu
suffici
detect
minimum
differ
unit
distress
score
henc
assum
type
error
power
measur
describ
individu
averag
profil
graph
accompani
confid
interv
assess
progress
wood
clinic
asthma
score
heart
rate
respiratori
rate
made
mean
student
test
pair
sampl
project
submit
approv
research
ethic
committe
hospit
israelita
albert
einstein
offici
opinion
number
caae
studi
includ
patient
admit
intens
treatment
unit
privat
hospit
paulo
januari
decemb
diagnos
bronchospasm
andor
wheez
age
rang
month
median
month
interquartil
interv
iqi
month
mean
length
stay
day
standard
deviat
sd
drug
treatment
chang
studi
bronchodil
salbutamol
use
case
oral
corticosteroid
prednisolon
given
occas
patient
receiv
intraven
corticosteroid
methylprednisolon
inhal
hyperton
solut
prescrib
patient
antibiot
treatment
consid
prophylact
maintain
hospit
three
patient
one
receiv
differ
type
medic
name
montelukast
fluticason
propion
fluticason
associ
salmeterol
respiratori
physic
therapi
done
patient
time
start
convent
treatment
introduct
show
median
hour
hour
variabl
evalu
clinic
outcom
shown
tabl
two
case
treatment
associ
noninvas
ventil
discontinu
due
treatment
failur
three
patient
two
minut
one
minut
one
requir
invas
mechan
ventil
mean
diseas
sever
score
time
point
zero
sd
time
point
minut
sd
differ
found
sever
score
statist
differ
minut
p
accord
present
figur
heart
rate
evalu
show
signific
first
time
point
studi
relev
sustain
figur
variat
respiratori
rate
show
similar
progress
sever
score
also
show
signific
minut
figur
observ
relat
day
hospit
sever
score
last
decad
number
studi
aim
confirm
efficaci
heliumoxygen
mixtur
use
obstruct
diseas
asthma
bronchiol
airway
obstruct
increas
studi
prove
particularli
import
sinc
provid
data
brazilian
popul
note
scarciti
result
clinic
applic
heliumoxygen
mixtur
especi
regard
pediatr
popul
cohort
studi
brazilian
popul
includ
infant
diagnos
acut
viral
bronchiol
mean
length
stay
day
studi
treatment
ill
convent
use
heliumoxygen
mixtur
wherea
studi
conduct
asthmat
children
also
without
use
mean
length
stay
day
studi
mean
length
stay
lower
yet
possibl
affirm
result
associ
use
liet
et
al
observ
relat
use
mixtur
reduct
hospit
time
regard
treatment
use
hospit
studi
show
high
rate
util
bronchodil
oral
steroid
treatment
strongli
recommend
global
initi
asthma
anoth
recommend
global
initi
asthma
would
use
heliox
one
hour
start
convent
drug
treatment
studi
time
start
drug
treatment
instal
heliumoxygen
mixtur
hour
datum
reinforc
result
improv
patient
relat
introduct
drug
treatment
effect
et
al
follow
nonintub
children
bronchiol
conclud
children
receiv
present
improv
respiratori
heart
rate
besid
remain
less
time
intens
care
unit
children
includ
studi
besid
distress
score
follow
respiratori
heart
rate
use
heliumoxygen
mixtur
show
signific
reduct
respiratori
distress
score
respiratori
rate
patient
first
minut
continu
reduct
minut
signific
improv
distress
score
first
minut
attribut
chang
airflow
pattern
becom
laminar
use
howev
progress
improv
children
throughout
time
may
relat
better
lung
deposit
inhal
drug
bronchodil
use
data
confirm
result
kress
et
al
conduct
random
studi
asthmat
children
receiv
albuterol
oxygen
observ
statist
signific
improv
forc
expiratori
volum
one
second
group
braun
filho
et
al
compar
administr
bronchodil
convent
manner
administr
inhal
medic
mixtur
helium
ga
observ
use
decreas
risk
perman
patient
observ
room
studi
three
patient
present
improv
distress
score
discontinu
one
use
invas
mechan
ventil
two
success
case
associ
noninvas
ventil
good
respons
associ
indic
sinc
noninvas
mechan
ventil
consid
synergist
complementari
therapi
point
howev
need
ventil
prepar
receiv
mixtur
limit
process
et
al
conduct
random
crossov
studi
infant
diagnos
bronchiol
note
signific
improv
respiratori
work
noninvas
mechan
ventil
associ
review
use
noninvas
mechan
ventil
reinforc
complementari
role
therapi
expos
associ
two
guarante
promis
futur
treatment
variou
ill
recent
studi
demonstr
use
highflow
nasal
cannula
signific
influenc
improv
oxygen
respiratori
rate
success
altern
futur
sinc
demand
access
equip
microprocess
ventil
use
noninvas
mechan
ventil
studi
chose
observ
case
bronchospasm
wheez
disord
improv
ga
exchang
decreas
respiratori
work
prevent
reintub
protocol
includ
children
maintain
moder
sever
sever
score
one
hour
convent
treatment
limit
number
children
includ
studi
sinc
major
children
obstruct
diseas
improv
convent
intervent
first
hour
anoth
limit
studi
retrospect
limit
result
interpret
still
consensu
use
heliumoxygen
mixtur
great
difficulti
conclus
differ
studi
design
inclus
criteria
diseas
sever
treatment
time
intervent
start
use
children
obstruct
diseas
show
posit
outcom
signific
reduct
distress
score
respiratori
rate
first
minut
use
therefor
consid
support
treatment
patient
respiratori
failur
obstruct
caus
